According to the latest data from the Hong Kong Stock Exchange, on May 19, Huatai-PineBridge Fund sold 160,000 shares of REMEGEN at an average price of HK$84.8306 per share, with a total transaction value of approximately HK$13.5729 million. Following this reduction, the fund's holding in REMEGEN stands at 10.3745 million shares, representing a 4.97% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.